Back

The value of CA125 in predicting adverse outcomes in heart failure patients

19 May 2025 (09:00 - 10:20)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure (3) Biomarkers HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Thai Hao Phan

University of Medicine Pham Ngoc Thach, Ho Chi Minh (Viet Nam)

5 More presentations in this session

Presentation thumbnail
Pulmonary hypertension severity and right ventricular function in acute cardiorenal syndrome: correlations with clinical and biochemical parameters
Doctor T. Georgopoulou (Heraklion, GR)
Abstract Slides Video
Presentation thumbnail
Rapid initial beta-blocker up-titration enhances cardiac adrenergic innervation improvement over a 12-month observation period
Doctor E. Dziewiecka (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
NT-proBNP as a marker of heart failure in haemodialysis patients
Doctor G. Mihelcic (London, GB)
Abstract Slides Video
Presentation thumbnail
Another cause for concern: guidelines versus real-world clinical practice in the evaluation of patients with acute heart failure
Assistant Professor V. Medovchshikov (Aktobe, KZ)
Abstract Slides Video
Presentation thumbnail
Variability in the diagnostic evaluation of patients with acute heart failure: data from a retrospective registry of five centers in West Kazakhstan
Doctor N. Yeshniyazov (Aktobe, KZ)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in acute heart failure (3)

The Event

Event poster

Heart Failure 2025

19 May 2025 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Carbohydrate antigen 125 as a biomarker for patients with acute heart failure in a nurse-based heart failure unit in a university hospital
thumbnail
Congress Presentation
Beyond NT-proBNP: Ca-125's distinctive role in heart failure - insights into right ventricular predominance and tricuspid regurgitation
thumbnail
Congress Presentation
Comparision value of CA125 with NT-proBNP in predicting fluid overload in heart failure patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources